Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease

被引:238
作者
Wu, ZH
Guo, H
Chow, NW
Sallstrom, J
Bell, RD
Deane, R
Brooks, AI
Kanagala, S
Rubio, A
Sagare, A
Liu, D
Li, F
Armstrong, D
Gasiewicz, T
Zidovetzki, R
Song, XM
Hofman, F
Zlokovic, BV
机构
[1] Univ Rochester, Med Ctr, Frank P Smith Labs Neurosci & Neurosurg Res, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Genom Ctr, Rochester, NY 14642 USA
[3] Socratech Res Labs, Rochester, NY 14620 USA
[4] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA
[5] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA
[6] Univ So Calif, Hoffman Med Res Ctr, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA
关键词
D O I
10.1038/nm1287
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurovascular dysfunction substantially contributes to Alzheimer disease. Here, we show that transcriptional profiling of human brain endothelial cells ( BECs) defines a subset of genes whose expression is age- independent but is considerably altered in Alzheimer disease, including the homeobox gene MEOX2 ( also known as GAX), a regulator of vascular differentiation, whose expression is low in Alzheimer disease. By using viral- mediated MEOX2 gene silencing and transfer, we show that restoring expression of the protein it encodes, GAX, in BECs from individuals with Alzheimer disease stimulates angiogenesis, transcriptionally suppresses AFX1 forkhead transcription factor - mediated apoptosis and increases the levels of a major amyloid- beta peptide ( Ab) clearance receptor, the low- density lipoprotein receptor - related protein 1 ( LRP), at the blood- brain barrier. In mice, deletion of Meox2 ( also known as Gax) results in reductions in brain capillary density and resting cerebral blood flow, loss of the angiogenic response to hypoxia in the brain and an impaired Ab efflux from brain caused by reduced LRP levels. The link of MEOX2 to neurovascular dysfunction in Alzheimer disease provides new mechanistic and therapeutic insights into this illness.
引用
收藏
页码:959 / 965
页数:7
相关论文
共 49 条
[1]  
Alzheimer A., 1907, ALLG Z PSYCHIAT, V64, P146, DOI DOI 10.1002/CA.980080612
[2]  
ANDRES V, 1995, MOL CELL BIOL, V15, P4272
[3]   Amyloid-β:: a chameleon walking in two worlds:: a review of the trophic and toxic properties of amyloid-β [J].
Atwood, CS ;
Obrenovich, ME ;
Liu, TB ;
Chan, H ;
Perry, G ;
Smith, MA ;
Martins, RN .
BRAIN RESEARCH REVIEWS, 2003, 43 (01) :1-16
[4]   The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease [J].
Bailey, TL ;
Rivara, CB ;
Rocher, AB ;
Hof, PR .
NEUROLOGICAL RESEARCH, 2004, 26 (05) :573-578
[5]   A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes [J].
Baldi, P ;
Long, AD .
BIOINFORMATICS, 2001, 17 (06) :509-519
[6]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[7]   Role of RAP in the biogenesis of lipoprotein receptors [J].
Bu, GJ ;
Marzolo, MP .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (04) :148-155
[8]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[9]   Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins [J].
Casserly, I ;
Topol, E .
LANCET, 2004, 363 (9415) :1139-1146
[10]   Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration [J].
Citron, BA ;
Suo, ZM ;
SantaCruz, K ;
Davies, PJA ;
Qin, F ;
Festoff, BW .
NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (01) :69-78